Amatuer, Your over-interpretation skills are impressive. Then you take your over-interpretation and run with it to make other definitive conclusions. NP vs BP: The guy running my company didn't like the price, so he switched labs to get a better price (as he said, he works for the shareholders). I loved his comments about not diluting the shareholders.
Leronlimab works. At this point, CYDY doesn't need to employ more scientists to study the MOA. Get approval, get revenue. Then hire people to work on Ohm20's list if you want.
BP has done some great work, and is shouting that Covid19 infection is a RANTES disease. He doesn't need us for that, and we don't need him. BP doesn't need to be there for his interpretation skills. CYDY doesn't need to own a lab operation. Just send the samples to a lab and get the results. Does the patient have an elevated white count? What's the differential? Those parts are not that hard.
If results are good, the spotlight will shine on many, including BP and his private lab company.
News 
Market Data 
Discover 
